3 Years after COVID: Hospitals Nationwide Maintaining Ventilators in Patient-Ready Condition with Support from US Med-Equip
Preventative maintenance, recall remediation, and other biomedical services surge for medical equipment stockpiled during the pandemic With life-saving medical equipment stockpiled during the COVID-19 pandemic...
10,000 Driving Confidence Course Milestone Since Covid
Covid had a dramatic impact on the world. The various lockdowns took a huge toll on people’s mental health and also confidence. Since the last...
Study Shows Faith, Spirituality Boost Mental Health, Especially During Isolation and Despair
Post-COVID, spirituality helped people be resilient A study released this week shows the positive effects of spiritual and religious engagement during COVID and similar times...
Novel Nanomaterial Air Purification Tech 10X Better than HEPA for Intercepting and Decomposing Organic Contaminants and Pathogens
Uses only Proprietary Material, Airflow and Daylight or LED; the LumaFlo technology is designed initially for hospitals, as well as crowded public spacesTEL AVIV, ISRAEL...
Company’s Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness in RSV in a Lethal Lung Disease Animal Model, Reports NanoViricides
SHELTON, CT / ACCESSWIRE / July 11, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies...
Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides
SHELTON, CO / ACCESSWIRE / July 6, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that the clinical trial of its broad-spectrum antiviral drug...
Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post Covid Syndrome’
Neobiosis, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of...
Eyam Announces Artificial Intelligence Research Facility in Partnership with Mitacs
VANCOUVER, BC / ACCESSWIRE / May 31, 2023 / Eyam announces today the opening of a new research facility in partnership with Mitacs, a national...
NanoViricides is Expanding its Broad-Spectrum Antiviral Program to Explore Further Antiviral Applications of its COVID Clinical Drug Ingredient
SHELTON, CT / ACCESSWIRE / April 25, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in the development of highly...
NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate
SHELTON, CT / ACCESSWIRE / April 17, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in nanomedicines against viruses, announced...